Live Breaking News & Updates on Recoverya group new investors

EpiEndo Pharmaceuticals beschafft in einer Serie-A-Finanzierungsrunde 20 Millionen Euro für die weitere klinische Entwicklung seines nicht-antibiotischen Makrolids zur Behandlung von COPD
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Reykjavik , C10 , Iceland , Stockholm , Sweden , Services-or-events , Concept-development , Holding-company-for-investments , Recoverya-group-new-investors , Forward-propositional-this-press , European-commission